(Q79121179)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14527908%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

title

Follow-up surveillance for recurrence after curative gastric cancer surgery lacks survival benefit (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14527908%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Follow-Up Surveillance for Recurrence After Curative Gastric Cancer Surgery Lacks Survival Benefit (English)

1 reference

https://api.crossref.org/works/10.1245/ASO.2003.12.009

18 March 2024

1 reference

https://api.crossref.org/works/10.1245/ASO.2003.12.009

18 March 2024

1 reference

https://api.crossref.org/works/10.1245/ASO.2003.12.009

18 March 2024

author name string

Yasuhiro Kodera

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14527908%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Seiji Ito

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14527908%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Yoshitaka Yamamura

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14527908%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Yoshinari Mochizuki

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14527908%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Michitaka Fujiwara

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14527908%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Kenji Hibi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14527908%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Katsuki Ito

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14527908%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Seiji Akiyama

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14527908%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Akimasa Nakao

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14527908%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14527908

18 March 2024

publication date

1 October 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14527908%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

19 December 2019

http://link.springer.com/article/10.1245/ASO.2003.12.009/fulltext.html

1 reference

https://api.crossref.org/works/10.1245/ASO.2003.12.009

http://link.springer.com/content/pdf/10.1245/ASO.2003.12.009.pdf

18 March 2024

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1245/ASO.2003.12.009

http://link.springer.com/content/pdf/10.1245/ASO.2003.12.009

18 March 2024

1 reference

https://api.crossref.org/works/10.1245/ASO.2003.12.009

Annals of Surgical Oncology

18 March 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14527908%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14527908%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14527908%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

page(s)

898-902

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14527908%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1245/aso.2003.12.009

19 December 2019

exact match

0 references

cites work

Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer

5

1 reference

https://api.crossref.org/works/10.1245/ASO.2003.12.009

Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer.

18 March 2024

6

1 reference

https://api.crossref.org/works/10.1245/ASO.2003.12.009

Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer

18 March 2024

7

1 reference

https://api.crossref.org/works/10.1245/ASO.2003.12.009

Phase II study of a combination of irinotecan and cisplatin against metastatic gastric cancer

18 March 2024

8

1 reference

https://api.crossref.org/works/10.1245/ASO.2003.12.009

Late phase II study of novel oral fluoropyrimidine anticancer drug S-1 (1 M tegafur-0.4 M gimestat-1 M otastat potassium) in advanced gastric cancer patients

18 March 2024

9

1 reference

https://api.crossref.org/works/10.1245/ASO.2003.12.009

Recurrence following curative resection for gastric carcinoma

18 March 2024

10

1 reference

https://api.crossref.org/works/10.1245/ASO.2003.12.009

Evaluation of a follow-up programme after curative resection for colorectal cancer

18 March 2024

11

1 reference

https://api.crossref.org/works/10.1245/ASO.2003.12.009

A new macroscopic classification predicts prognosis for patient with liver metastases from colorectal cancer

18 March 2024

12

1 reference

https://api.crossref.org/works/10.1245/ASO.2003.12.009